vs
Side-by-side financial comparison of HANMI FINANCIAL CORP (HAFC) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $71.2M, roughly 1.1× HANMI FINANCIAL CORP). HANMI FINANCIAL CORP runs the higher net margin — 29.8% vs 7.4%, a 22.4% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 17.1%). HANMI FINANCIAL CORP produced more free cash flow last quarter ($203.7M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 10.4%).
Hanmi Bank Corporation is a community bank headquartered in Los Angeles, California, with 35 branches and eight loan production offices in California, Texas, Illinois, New York, New Jersey and Virginia.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
HAFC vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $71.2M | $76.2M |
| Net Profit | $21.2M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | 29.8% | 11.0% |
| Net Margin | 29.8% | 7.4% |
| Revenue YoY | 17.1% | 25.5% |
| Net Profit YoY | 20.0% | 30.7% |
| EPS (diluted) | $0.70 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $71.2M | $76.2M | ||
| Q3 25 | $71.0M | $71.9M | ||
| Q2 25 | $65.2M | $63.1M | ||
| Q1 25 | $62.8M | $59.1M | ||
| Q4 24 | $60.8M | $60.7M | ||
| Q3 24 | $58.5M | $58.0M | ||
| Q2 24 | $56.7M | $55.0M | ||
| Q1 24 | $58.4M | $50.6M |
| Q4 25 | $21.2M | $5.6M | ||
| Q3 25 | $22.1M | $3.5M | ||
| Q2 25 | $15.1M | $3.2M | ||
| Q1 25 | $17.7M | $2.6M | ||
| Q4 24 | $17.7M | $4.3M | ||
| Q3 24 | $14.9M | $3.9M | ||
| Q2 24 | $14.5M | $1.5M | ||
| Q1 24 | $15.2M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | 29.8% | 11.0% | ||
| Q3 25 | 31.1% | 7.8% | ||
| Q2 25 | 23.2% | 8.1% | ||
| Q1 25 | 28.1% | 6.5% | ||
| Q4 24 | 29.1% | 10.6% | ||
| Q3 24 | 25.5% | 9.7% | ||
| Q2 24 | 25.5% | 6.6% | ||
| Q1 24 | 26.0% | 4.4% |
| Q4 25 | 29.8% | 7.4% | ||
| Q3 25 | 31.1% | 4.9% | ||
| Q2 25 | 23.2% | 5.0% | ||
| Q1 25 | 28.1% | 4.4% | ||
| Q4 24 | 29.1% | 7.1% | ||
| Q3 24 | 25.5% | 6.7% | ||
| Q2 24 | 25.5% | 2.7% | ||
| Q1 24 | 26.0% | 3.2% |
| Q4 25 | $0.70 | $0.14 | ||
| Q3 25 | $0.73 | $0.09 | ||
| Q2 25 | $0.50 | $0.08 | ||
| Q1 25 | $0.58 | $0.06 | ||
| Q4 24 | $0.58 | $0.10 | ||
| Q3 24 | $0.49 | $0.10 | ||
| Q2 24 | $0.48 | $0.04 | ||
| Q1 24 | $0.50 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $796.4M | $141.5M |
| Total Assets | $7.9B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.5M | ||
| Q3 25 | — | $11.1M | ||
| Q2 25 | — | $20.0M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $17.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $8.8M | ||
| Q1 24 | — | $7.3M |
| Q4 25 | $796.4M | $141.5M | ||
| Q3 25 | $779.5M | $133.6M | ||
| Q2 25 | $762.8M | $139.7M | ||
| Q1 25 | $751.5M | $134.8M | ||
| Q4 24 | $732.2M | $131.4M | ||
| Q3 24 | $736.7M | $125.0M | ||
| Q2 24 | $707.1M | $119.4M | ||
| Q1 24 | $703.1M | $116.3M |
| Q4 25 | $7.9B | $199.2M | ||
| Q3 25 | $7.9B | $202.4M | ||
| Q2 25 | $7.9B | $184.6M | ||
| Q1 25 | $7.7B | $178.1M | ||
| Q4 24 | $7.7B | $177.1M | ||
| Q3 24 | $7.7B | $169.5M | ||
| Q2 24 | $7.6B | $163.9M | ||
| Q1 24 | $7.5B | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $206.0M | $18.4M |
| Free Cash FlowOCF − Capex | $203.7M | $9.7M |
| FCF MarginFCF / Revenue | 286.2% | 12.7% |
| Capex IntensityCapex / Revenue | 3.2% | 11.5% |
| Cash ConversionOCF / Net Profit | 9.70× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $356.1M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $206.0M | $18.4M | ||
| Q3 25 | $146.9M | $18.4M | ||
| Q2 25 | $-19.0M | $12.3M | ||
| Q1 25 | $25.8M | $2.9M | ||
| Q4 24 | $52.6M | $15.0M | ||
| Q3 24 | $6.7M | $12.7M | ||
| Q2 24 | $2.1M | $10.2M | ||
| Q1 24 | $30.0M | $1.2M |
| Q4 25 | $203.7M | $9.7M | ||
| Q3 25 | $146.4M | $10.7M | ||
| Q2 25 | $-19.6M | $4.1M | ||
| Q1 25 | $25.6M | $-12.6M | ||
| Q4 24 | $49.9M | $3.2M | ||
| Q3 24 | $6.5M | $1.7M | ||
| Q2 24 | $1.3M | $1.2M | ||
| Q1 24 | $29.2M | $-4.8M |
| Q4 25 | 286.2% | 12.7% | ||
| Q3 25 | 206.3% | 14.9% | ||
| Q2 25 | -30.0% | 6.5% | ||
| Q1 25 | 40.7% | -21.4% | ||
| Q4 24 | 82.1% | 5.2% | ||
| Q3 24 | 11.1% | 3.0% | ||
| Q2 24 | 2.3% | 2.3% | ||
| Q1 24 | 50.0% | -9.5% |
| Q4 25 | 3.2% | 11.5% | ||
| Q3 25 | 0.8% | 10.6% | ||
| Q2 25 | 0.9% | 12.9% | ||
| Q1 25 | 0.4% | 26.2% | ||
| Q4 24 | 4.3% | 19.5% | ||
| Q3 24 | 0.4% | 19.0% | ||
| Q2 24 | 1.4% | 16.3% | ||
| Q1 24 | 1.4% | 11.9% |
| Q4 25 | 9.70× | 3.27× | ||
| Q3 25 | 6.66× | 5.23× | ||
| Q2 25 | -1.26× | 3.88× | ||
| Q1 25 | 1.46× | 1.09× | ||
| Q4 24 | 2.97× | 3.47× | ||
| Q3 24 | 0.45× | 3.29× | ||
| Q2 24 | 0.14× | 6.94× | ||
| Q1 24 | 1.98× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
